Dechra Pharmaceuticals PLC

Major Shareholding Notification • Jan 16, 2024

National Storage Mechanism | Additional information

RNS Number : 8889Z

Dechra Pharmaceuticals PLC

16 January 2024

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB0009633180

Issuer Name

DECHRA PHARMACEUTICALS PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

JPMorgan Chase & Co.

City of registered office (if applicable)

Country of registered office (if applicable)

US

4. Details of the shareholder

Name	City of registered office	Country of registered office
J.P. Morgan Securities plc

5. Date on which the threshold was crossed or reached

12-Jan-2024

6. Date on which Issuer notified

16-Jan-2024

7. Total positions of person(s) subject to the notification obligation

	% of voting rights attached to shares (total of 8.A)	% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)	Total of both in % (8.A + 8.B)	Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached	8.271846	0.315854	8.587700	9781946
Position of previous notification (if applicable)	7.916218	0.297637	8.213855

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)	Number of direct voting rights (DTR5.1)	Number of indirect voting rights (DTR5.2.1)	% of direct voting rights (DTR5.1)	% of indirect voting rights (DTR5.2.1)
GB0009633180		9422134		8.271846
Sub Total 8.A	9422134		8.271846%

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument	Expiration date	Exercise/conversion period	Number of voting rights that may be acquired if the instrument is exercised/converted	% of voting rights
Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument	Expiration date	Exercise/conversion period	Physical or cash settlement	Number of voting rights	% of voting rights
Cash-settled Equity Swap	20/02/2024	20/02/2024	Cash	6220	0.005451
Cash-settled Equity Swap	04/03/2024	04/03/2024	Cash	5090	0.004468
Cash-settled Equity Swap	27/06/2024	27/06/2024	Cash	880	0.000772
Cash-settled Equity Swap	31/07/2024	31/07/2024	Cash	39012	0.034249
Cash-settled Equity Swap	17/10/2024	17/10/2024	Cash	68288	0.059951
Cash-settled Equity Swap	04/11/2024	04/11/2024	Cash	17	0.000014
Cash-settled Equity Swap	20/11/2024	20/11/2024	Cash	500	0.000438
Cash-settled Equity Swap	27/12/2024	27/12/2024	Cash	4313	0.003783
Cash-settled Equity Swap	22/01/2025	22/01/2025	Cash	202956	0.178178
Cash-settled Equity Swap	04/02/2025	04/02/2025	Cash	5556	0.004870
Cash-settled Equity Swap	11/02/2025	11/02/2025	Cash	4200	0.003685
Cash-settled Equity Swap	17/02/2025	17/02/2025	Cash	15886	0.013944
Cash-settled Equity Swap	18/06/2027	18/06/2027	Cash	6891	0.006049
Cash-settled Equity Swap	30/05/2028	30/05/2028	Cash	3	0.000002
Sub Total 8.B2				359812	0.315854%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person	Name of controlled undertaking	% of voting rights if it equals or is higher than the notifiable threshold	% of voting rights through financial instruments if it equals or is higher than the notifiable threshold	Total of both if it equals or is higher than the notifiable threshold
JPMorgan Chase & Co.	J.P. Morgan Securities plc	8.245585		8.561439%
JPMorgan Chase & Co.	J.P. Morgan Securities LLC
JPMorgan Chase & Co.	J.P. Morgan SE
JPMorgan Chase & Co.	J.P. Morgan Markets Limited

10. In case of proxy voting

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional Information

Chain of controlled undertakings:

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan Capital Holdings Limited (100%)

J.P. Morgan Securities plc (100%)

JPMorgan Chase & Co.

JPMorgan Chase Holdings LLC (100%)

J.P. Morgan Broker-Dealer Holdings Inc. (100%)

J.P. Morgan Securities LLC (100%)

JPMorgan Chase & Co.

JPMorgan Chase Bank, National Association (100%)

J.P. Morgan International Finance Limited (100%)

J.P. Morgan SE (100%)

JPMorgan Chase & Co.

JPMorgan Chase Holdings LLC (100%)

Bear Stearns Irish Holdings LLC (100%)

J.P. MORGAN FINANCIAL INVESTMENTS LIMITED (100%)

J.P. MORGAN MARKETS LIMITED (100%)

12. Date of Completion

16-Jan-2024

13. Place Of Completion

London, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

HOLUNSSRSAUAAAR